{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:57:07Z","timestamp":1793890627525,"version":"4.8.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"National Regional Medical Center Opening Project (NRMC0107)."}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Thrombotic disease is a rare but severe complication of <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic> pneumonia in children, with pulmonary thrombosis (PT) being the most frequent type. This study aims to describe the clinical features of pediatric severe <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic> pneumonia (SMPP) patients with PT, and to identify risk factors predictive of PT development in this population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively enrolled 60 children with SMPP complicated by PT who were admitted to Children\u2019s Hospital Affiliated to Zhengzhou University from January 2019 to October 2023. We reviewed their demographic data, laboratory tests and imaging examinations to describe their clinical features. We used multivariate logistic regression analysis to identify significant risk factors for PT in SMPP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The PT group exhibited higher incidences of chest pain, hemoptysis, inflammation and elevated D-dimer levels, as well as more severe pulmonary damage and transaminitis complication, compared to the non-PT group. The left pulmonary artery was the predominant location of PT in SMPP children. A multivariate analysis revealed that C-reactive protein (CRP) and D-dimer were significant predictors of PT in SMPP patients, with odds ratios of 1.10 and 3.37, respectively. The optimal cutoff values of CRP and D-dimer for predicting PT in SMPP were 76.73\u2009mg\/L and 3.98 \u00b5g\/mL, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In SMPP, CRP &gt;76.73\u2009mg\/L and D-dimer &gt;3.98 \u00b5g\/mL are independent predictors of PT. These findings suggest that SMPP-induced excessive inflammation may contribute to PT pathogenesis. Early and intensive anticoagulant, anti-inflammatory and antimycoplasma therapy may improve the disease course and prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004287","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:04:35Z","timestamp":1708031075000},"page":"505-510","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Pulmonary Thrombotic Complication of Mycoplasma pneumoniae Pneumonia in Chinese Children: Clinical Feature and Risk Factor Analysis"],"prefix":"10.1097","volume":"43","author":[{"given":"Yanjuan","family":"Yu","sequence":"first","affiliation":[{"name":"From the Respiratory Department, Children\u2019s Hospital Affiliated to Zhengzhou University, Henan Children\u2019s Hospital, Zhengzhou Children\u2019s Hospital, Zhengzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhong","family":"Jin","sequence":"additional","affiliation":[{"name":"From the Respiratory Department, Children\u2019s Hospital Affiliated to Zhengzhou University, Henan Children\u2019s Hospital, Zhengzhou Children\u2019s Hospital, Zhengzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Respiratory Department, Children\u2019s Hospital Affiliated to Zhengzhou University, Henan Children\u2019s Hospital, Zhengzhou Children\u2019s Hospital, Zhengzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3206-610X","authenticated-orcid":false,"given":"Yuelin","family":"Shen","sequence":"additional","affiliation":[{"name":"Respiratory Department II, National Clinical Research Center for Respiratory Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12026-019-09096-6","article-title":"Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia.","volume":"67","author":"Wang","year":"2019","journal-title":"Immunol Res"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11547-021-01442-9","article-title":"Dual-energy spectral CT imaging of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children.","volume":"127","author":"Yang","year":"2022","journal-title":"Radiol Med"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/etm.2021.9634","article-title":"Mycoplasma pneumoniae pneumonia with pulmonary embolism: a study on pediatric cases in Jilin province of China.","volume":"21","author":"Sheng","year":"2021","journal-title":"Exp Ther Med"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12879-020-4774-9","article-title":"Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing children\u2019s hospital.","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13052-022-01344-0","article-title":"Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study.","volume":"48","author":"Han","year":"2022","journal-title":"Ital J Pediatr"},{"key":"R6-20250614","first-page":"1386","article-title":"Clinical analysis and etiology factors of pulmonary embolism in 30 children.","volume":"37","author":"Liu","year":"2022","journal-title":"Chin J Appl Clin Pediatr"},{"key":"R7-20250614","first-page":"11574","article-title":"Mycoplasma pneumoniae pneumonia complicated with pulmonary embolism: a systematic analysis of published case reports.","volume":"9","author":"Huang","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"R8-20250614","first-page":"291","article-title":"Guidelines for diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023 Edition).","volume":"36","year":"2023","journal-title":"Infect Dis Info"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3348\/kjr.2016.17.2.198","article-title":"Advances in multidetector CT diagnosis of pediatric pulmonary thromboembolism.","volume":"17","author":"Thacker","year":"2016","journal-title":"Korean J Radiol"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"e24297","DOI":"10.1097\/MD.0000000000024297","article-title":"Cardiac thrombus and stroke in a child with Mycoplasma pneumoniae pneumonia: a case report.","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ppul.25298","article-title":"Cases of macrolide-resistant Mycoplasma pneumoniae pneumonia-associated pulmonary thromboembolism.","volume":"56","author":"Kim","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"e0103","DOI":"10.1097\/MD.0000000000010103","article-title":"Refractory Mycoplasma pneumoniae pneumonia with concomitant acute cerebral infarction in a child: a case report and literature review.","volume":"97","author":"Jin","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R13-20250614","first-page":"10061","article-title":"Venous thromboembolism during Mycoplasma pneumoniae infection: case report and review of the literature.","volume":"24","author":"Mirijello","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pcl.2018.02.002","article-title":"Pulmonary embolism in children.","volume":"65","author":"Ramiz","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/ppul.25527","article-title":"Pulmonary embolism in pediatric age: a retrospective study from a tertiary center.","volume":"56","author":"Lopes de Bragan\u00e7a","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2352-3026(18)30224-2","article-title":"Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.","volume":"6","author":"Pelland-Marcotte","year":"2019","journal-title":"Lancet Haematol"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/crj.13584","article-title":"Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children.","volume":"17","author":"Chen","year":"2023","journal-title":"Clin Respir J"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fmicb.2016.00023","article-title":"Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis.","volume":"7","author":"Narita","year":"2016","journal-title":"Front Microbiol"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1177\/0300060517709613","article-title":"Evaluation of variation in coagulation among children with Mycoplasma pneumoniae pneumonia: a case-control study.","volume":"45","author":"Li","year":"2017","journal-title":"J Int Med Res"},{"key":"R20-20250614","first-page":"541","article-title":"Role of anti-inflammatory cytokines in pathogenesis of pediatric Mycoplasma pneumoniae pneumonia.","volume":"30","author":"Yan","year":"2016","journal-title":"J Biol Regul Homeost Agents"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1038\/s41598-019-43451-9","article-title":"Immunosuppression reduces lung injury caused by Mycoplasma pneumoniae infection.","volume":"9","author":"Shi","year":"2019","journal-title":"Sci Rep"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/crj.12196","article-title":"Predictive value of serum Hs-CRP levels for outcomes of pulmonary embolism.","volume":"10","author":"Araz","year":"2016","journal-title":"Clin Respir J"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10654-017-0277-4","article-title":"Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.","volume":"32","author":"Kunutsor","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ppul.20739","article-title":"Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors.","volume":"43","author":"Brown","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"bcr1220103561","DOI":"10.1136\/bcr.12.2010.3561","article-title":"M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies.","volume":"2011","author":"Ascer","year":"2011","journal-title":"BMJ Case Rep"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A test in context: D-Dimer.","volume":"70","author":"Weitz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"87391","DOI":"10.3389\/fcimb.2021.687391","article-title":"The level of D-Dimer Is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children.","volume":"11","author":"Zheng","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PEC.0000000000001730","article-title":"Pulmonary embolism in children.","volume":"35","author":"Navanandan","year":"2019","journal-title":"Pediatr Emerg Care"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s12879-020-05110-7","article-title":"The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children.","volume":"20","author":"Zheng","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children.","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.","volume":"57","author":"Tamura","year":"2008","journal-title":"J Infect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:02:09Z","timestamp":1749945729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004287","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}